Health

Results: 8053-8064 of 9392

PR Newswire associated0

Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.

Sales of Leqembi® totaled 1.1 billion yen in the fourth quarter 2023

Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit and Differentiated Safety Profile

Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)

Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis

PR Newswire associated0

Amplity Health Announces Leadership Changes

1 in 5 on NHS waiting lists risk holiday healthcare fees

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT JANUARY 2024

Elsevier launches Complete HeartX, the world’s first heart education experience in spatial computing

Curia Receives 2024 CDMO Leadership Award

Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain

Silence Therapeutics Announces Oversubscribed $120 Million Private Placement